RNAi-mediated PTB depletion leads to enhanced exon definition

Molecular Cell

Volumn 10, Issue 4, 2002, Pages 943-949

  Wagner, Eric J ^a   Garcia Blanco, Mariano A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; HYBRID PROTEIN; PROTEIN DERIVATIVE; PROTEIN MS2; PROTEIN PTB; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; EXON; GENE; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; NONHUMAN; PROTEIN DEPLETION; PROTEIN DNA BINDING; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SILENCER GENE;

ANIMALIA;

EID: 0036810248     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00645-7     Document Type: Article

References (33)

1. Berget S.M. Exon recognition in vertebrate splicing. J. Biol. Chem. 270:1995;2411-2414.
2. Carstens R.P., McKeehan W.L., Garcia-Blanco M.A. An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing. Mol. Cell. Biol. 18:1998;2205-2217.
3. Carstens R.P., Wagner E.J., Garcia-Blanco M.A. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Mol. Cell. Biol. 20:2000;7388-7400.
4. Chan R.C., Black D.L. The polypyrimidine tract binding protein binds upstream of neural cell- specific c-src exon N1 to repress the splicing of the intron downstream. Mol. Cell. Biol. 17:1997;4667-4676.
5. Charlet B.N., Logan P., Singh G., Cooper T.A. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell. 9:2002;649-658.
6. Chou M.Y., Underwood J.G., Nikolic J., Luu M.H., Black D.L. Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol. Cell. 5:2000;949-957.
7. Cote J., Dupuis S., Wu J.Y. Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion. J. Biol. Chem. 276:2001;8535-8543.
8. De Moerlooze L., Spencer-Dene B., Revest J., Hajihosseini M., Rosewell I., Dickson C. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development. 127:2000;483-492.
9. Del Gatto F., Breathnach R. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 15:1995;4825-4834.
10. Del Gatto F., Plet A., Gesnel M.C., Fort C., Breathnach R. Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 17:1997;5106-5116.
11. Del Gatto-Konczak F., Olive M., Gesnel M.C., Breathnach R. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19:1999;251-260.
12. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
13. Garcia-Blanco M.A., Jamison S.F., Sharp P.A. Identification and purification of a 62,000-dalton protein that binds specifically to the polypyrimidine tract of introns. Genes Dev. 3:1989;1874-1886.
14. Gooding C., Roberts G.C., Smith C.W. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon. RNA. 4:1998;85-100.
15. Grossman J.S., Meyer M.I., Wang Y.C., Mulligan G.J., Kobayashi R., Helfman D.M. The use of antibodies to the polypyrimidine tract binding protein (PTB) to analyze the protein components that assemble on alternatively spliced pre-mRNAs that use distant branch points. RNA. 4:1998;613-625.
16. Hajihosseini M.K., Wilson S., De Moerlooze L., Dickson C. A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. Proc. Natl. Acad. Sci. USA. 98:2001;3855-3860.
17. Hannon G.J. RNA interference. Nature. 418:2002;244-251.
18. Jin W., McCutcheon I.E., Fuller G.N., Huang E.S., Cote G.J. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res. 60:2000;1221-1224.
19. Jones R.B., Wang F., Luo Y., Yu C., Jin C., Suzuki T., Kan M., McKeehan W.L. The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAs. J. Biol. Chem. 276:2001;4158-4167.
20. Le Guiner C., Plet A., Galiana D., Gesnel M.C., Del Gatto-Konczak F., Breathnach R. Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences. J. Biol. Chem. 276:2001;43677-43687.
21. Liu H., Zhang W., Reed R.B., Liu W., Grabowski P.J. Mutations in RRM4 uncouple the splicing repression and RNA-binding activities of polypyrimidine tract binding protein. RNA. 8:2002;137-149.
22. Markovtsov V., Nikolic J.M., Goldman J.A., Turck C.W., Chou M.Y., Black D.L. Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol. Cell. Biol. 20:2000;7463-7479.
23. Matsubara A., Kan M., Feng S., McKeehan W.L. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res. 58:1998;1509-1514.
24. Miki T., Bottaro D.P., Fleming T.P., Smith C.L., Burgess W.H., Chan A.M., Aaronson S.A. Determination of ligand-binding specificity by alternative splicing. two distinct growth factor receptors encoded by a single gene Proc. Natl. Acad. Sci. USA. 89:1992;246-250.
25. Mulligan G.J., Guo W., Wormsley S., Helfman D.M. Polypyrimidine tract binding protein interacts with sequences involved in alternative splicing of beta-tropomyosin pre-mRNA. J. Biol. Chem. 267:1992;25480-25487.
26. Norton P.A. Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding. Nucleic Acids Res. 22:1994;3854-3860.
27. Singh R., Valcarcel J., Green M.R. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science. 268:1995;1173-1176.
28. Smith C.W., Valcarcel J. Alternative pre-mRNA splicing. the logic of combinatorial control Trends Biochem. Sci. 25:2000;381-388.
29. Southby J., Gooding C., Smith C.W. Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actinin mutually exclusive exons. Mol. Cell. Biol. 19:1999;2699-2711.
30. Wagner E.J., Carstens R.P., Garcia-Blanco M.A. A novel isoform ratio switch of the polypyrimidine tract binding protein. Electrophoresis. 20:1999;1082-1086.
31. Wagner E.J., Garcia-Blanco M.A. Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 21:2001;3281-3288.
32. Wiegand H.L., Coburn G.A., Zeng Y., Kang Y., Bogerd H.P., Cullen B.R. Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes. Mol. Cell. Biol. 22:2002;245-256.
33. Wollerton M.C., Gooding C., Robinson F., Brown E.C., Jackson R.J., Smith C.W. Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein (PTB). RNA. 7:2001;819-832.